FDA Adverse Event Malfunction Summary report: N

BD PHASEAL OPTIMA CONNECTOR

MDR report key: 12512066 · Received September 22, 2021

Report

Report Number
3003152976-2021-00624
Event Type
Malfunction
Date Received
September 22, 2021
Date of Event
August 26, 2021
Report Date
November 4, 2021
Manufacturer
BECTON DICKINSON, S.A.
Product Code
ONB
UDI-DI
00382905150708
PMA / PMN Number
K181221
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D4: MEDICAL DEVICE LOT #: 2011504. D4: MEDICAL DEVICE EXPIRATION DATE: 2022-01-31. H4: DEVICE MANUFACTURE DATE: 2020-11-20. D10: DEVICE AVAILABLE FOR EVAL YES. D10: RETURNED TO MANUFACTURER ON: 2021-11-03. H6: INVESTIGATION SUMMARY: TWO UNUSED SAMPLES RECEIVED FOR INVESTIGATION, ONE OPTIMA INJECTOR AND ONE OPTIMA CONNECTOR. UPON A VISUAL INSPECTION, NO DAMAGES OR ANOMALIES WERE OBSERVED ON THE SAMPLES. NINE RETAINED SAMPLES FROM THE SAME LOTS WERE EVALUATED, AND LUER LOCK MEASURED, NO DAMAGE OR DEFECTS OBSERVED, MEASUREMENTS MET ACCEPTANCE CRITERIA. THE PRODUCT WAS VISUALLY INSPECTED AND NO DEFECTS WERE IDENTIFIED. FUNCTIONAL TESTING WAS PERFORMED, CONNECTING THE INJECTOR TO A SAMPLE SYRINGE, PROTECTOR AND VIAL ACCORDING TO THE INSTRUCTIONS FOR USE. IN ALL CASES THE PRODUCT FUNCTIONED PROPERLY, AND NO ISSUES WERE OBSERVED. A DEVICE HISTORY REVIEW WAS PERFORMED NO DEVIATIONS OR NON-CONFORMANCES WERE IDENTIFIED DURING THE MANUFACTURING PROCESS THAT COULD HAVE CONTRIBUTED TO THIS ISSUE. BASED ON THE VARIOUS TESTS WHERE THE OPTIMA INJECTORS N40-O AND OPTIMA CONNECTORS ARE LUER CONNECTED TO DIFFERENT MATTING COMPONENTS OVER MULTIPLE PENETRATIONS, AND ENGAGED/DISENGAGEMENT TEST WERE PERFORMED, IF ANY INCIDENT RELATED TO THE FAILURE HAVE OCCURRED IT WOULD HAVE BEEN DETECTED. PRODUCT UNDERGOES A SERIES OF INSPECTIONS THROUGHOUT THE MANUFACTURING PROCESS TO ENSURE THE QUALITY AND FUNCTIONALITY OF THE DEVICE, INCLUDING FLOW RATE VERIFICATION. FUNCTIONAL TESTING WAS PERFORMED, PENETRATING THE INJECTOR ALONG WITH A SAMPLE SYRINGE AND MATING COMPONENTS TEN TIMES, ALL RESULTS WERE FOUND TO BE ACCEPTABLE WITH NO LEAKS IDENTIFIED. IT SHOULD BE CONSIDERED THAT INJECTOR/CONNECTOR SEPARATION FAILURE MODE IS A DRY DISCONNECT WHICH PREVENTS LEAKAGE BY DESIGN. IT IS RECOMMENDED TO USE THE OPTIONAL M25-O CLAMP TO AVOID DRY DISCONNECTS DURING USE. BASED ON THE AVAILABLE INFORMATION WE ARE NOT ABLE TO IDENTIFY A ROOT CAUSE RELATED TO THE MANUFACTURING PROCESS AT THIS TIME. H3 OTHER TEXT: SEE H10.

Description of Event or Problem · 0

IT WAS REPORTED TWO BD PHASEAL OPTIMA CONNECTORS HAD A LOOSE INJECTOR/SEPARATION OF INJECTOR AND MATING COMPONENT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "RN ENTERED PATIENT ROOM TO TROUBLESHOOT AND OBSERVED THAT THE CLOSED SYSTEM TRANSFER DEVICE HAD BECOME DISCONNECTED BETWEEN THE INJECTOR AND CONNECTOR PORTIONS. BOTH PORTIONS OF IT WERE STILL SECURED ON PATIENT LINE AND END OF IV LINE. RN CLEANED THE CONNECTOR PORTION AND REATTACHED SECURELY AND TAPED CONNECTION (INFUSION CLAMP WAS NOT USED). APPROX 60 MINUTES LATER ABOUT AN HOUR LATER THE PUMP RANG DOWNSTREAM OCCLUSION AGAIN AND THE CONNECTOR/INJECTOR WAS AGAIN DISCONNECTED DESPITE BEING TAPED."

Additional Manufacturer Narrative · 1

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. DEVICE MANUFACTURE DATE: UNKNOWN.

Description of Event or Problem · 1

IT WAS REPORTED TWO BD PHASEAL OPTIMA CONNECTORS HAD A LOOSE INJECTOR/SEPARATION OF INJECTOR AND MATING COMPONENT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "RN ENTERED PATIENT ROOM TO TROUBLESHOOT AND OBSERVED THAT THE CLOSED SYSTEM TRANSFER DEVICE HAD BECOME DISCONNECTED BETWEEN THE INJECTOR AND CONNECTOR PORTIONS. BOTH PORTIONS OF IT WERE STILL SECURED ON PATIENT LINE AND END OF IV LINE. RN CLEANED THE CONNECTOR PORTION AND REATTACHED SECURELY AND TAPED CONNECTION (INFUSION CLAMP WAS NOT USED). APPROX 60 MINUTES LATER ABOUT AN HOUR LATER THE PUMP RANG DOWNSTREAM OCCLUSION AGAIN AND THE CONNECTOR/INJECTOR WAS AGAIN DISCONNECTED DESPITE BEING TAPED."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1410277 BD PHASEAL OPTIMA CONNECTOR INTRAVASCULAR ADMINISTRATION SET ONB BECTON DICKINSON, S.A. 2011504 00382905150708

Patients

Seq Age Sex Outcome Treatment
1 Unknown